MEDICO

Medico Remedies Ltd.

NSE: MEDICO

BSE: 540937

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

41.84-0.2 (-0.45%)

25 Aug, 12:59 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

48.7 / 100

Value Score

50.8 / 100

Price Momentum Score

42.7 / 100

QVM Score

40.3 / 100

Key Metrics

Market Cap

349.28

P/E (TTM)

25.28

P/B

4.63

P/S (TTM)

1.47

EV/EBITDA

20.84

CAPE (5Y)

40.03

ROE (TTM)

19.02

ROCE (TTM)

16.21

ROA (TTM)

9.60

Avg 3Y ROE

17.94

Earnings 3Y CAGR

19.02

Sales 3Y CAGR

19.62

Sales 5Y CAGR

11.02

Debt/Equity

0.25

Consensus TP

Strong Buy %

Promoter Holding

61.38

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Medico Remedies Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

High and stable ROE

The company reported strong ROE of 19.02% for 12-month ended 30 Jun 2026 and ROE improved marginally by 144 bps from 1 year ago

What is ROE (FY)?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 49.96% for 12-month ended 30 Jun 2026 and the growth was 39.37 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 10.59

Value 49.96

-99.6111701.8

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 32.49% for 12-month ended 30 Jun 2026 and the growth was 25.29 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.25 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Negative

Low but stable operating margin

The company reported low operating margin of 6.08% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -148 bps from 1 year ago

What is Operating profit margin?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Stock appears expensive but is at a discount to industry median P/E

PE TTM of 25.28 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -17.3%

What is P/E Ratio?

Median: 30.57

Value 25.28

-0.85775.12

Company's earnings are of moderate quality

Earnings quality score of 36.5 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

36.5 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Medico Remedies Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Medico Remedies Ltd. Shareholding Pattern

Quarterly breakdown of Medico Remedies Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2018	Mar 2019	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	66.83	63.79	62.59	61.38	61.38	61.38	61.38
Indian Promoter	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	73.34	66.83	63.79	62.59	61.38	61.38	61.38	61.38
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.53	1.20	1.12	1.29	1.03	1.20	1.19	1.17	0.13	0.08	0.31	0.49	0.03	0.08
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.53	1.19	1.11	1.29	0.29	0.22	0.22	0.39	0.11	0.07	0.30	0.49	0.03	0.08
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.74	0.97	0.97	0.78	0.01	0.01	0.01	0.00	0.00	0.00
Non-Institution	26.66	26.66	26.66	26.66	26.66	26.66	26.66	26.66	26.66	26.66	26.66	26.66	26.14	25.47	25.55	25.37	25.63	25.47	25.47	32.00	36.08	37.33	38.30	38.13	38.59	38.54
Bodies Corporate	20.42	20.85	-	-	19.93	18.16	19.61	19.16	19.25	19.19	16.62	13.49	11.22	9.78	9.45	7.66	6.29	2.14	2.04	4.59	4.62	4.76	5.45	5.42	4.81	4.72
Others (incl. Retail) No. of shareholders	6.24 122	5.81 105	26.66 113	26.66 111	6.73 98	8.50 89	7.05 70	7.50 101	7.41 100	7.47 477	10.04 750	13.17 1,740	14.92 3,256	15.69 5,013	16.10 5,221	17.71 6,007	19.34 10,641	23.33 12,852	23.43 12,833	27.41 14,014	31.46 15,346	32.57 16,396	32.85 18,418	32.71 16,482	33.78 16,107	33.82 15,786

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Medico Remedies Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Harshit H Mehta HUF Promoter	December-2024	Market Sale (Disposal) 26th Dec 2024	0.32 %	₹ 48.52	2.50 lac	₹ 1.21 cr
Harshit H Mehta HUF Promoter	December-2024	Market Sale (Disposal) 26th Dec 2024	0.80 %	₹ 49.01	4.00 lac	₹ 1.96 cr
Shweta Harshit Mehta Promoter Group	December-2024	Market Sale (Disposal) 26th Dec 2024	7.66 %	₹ 48.50	2.00 lac	₹ 97.00 lac
Rishit Haresh Mehta Promoter Group	December-2024	Market Sale (Disposal) 5th Dec 2024	13.13 %	₹ 45.02	4.00 lac	₹ 1.80 cr
Rishit Haresh Mehta Promoter Group	December-2024	Market Sale (Disposal) 5th Dec 2024	14.82 %	₹ 45.01	14.00 lac	₹ 6.30 cr
Harshit H Mehta HUF Promoter	November-2024	Market Sale (Disposal) 20th Nov 2024	0.87 %	₹ 50.65	52.94 k	₹ 26.81 lac
Rita Haresh Mehta Promoter	November-2024	Market Sale (Disposal) 20th Nov 2024	10.40 %	₹ 50.69	18.00 lac	₹ 9.13 cr
Shweta Harshit Mehta Promoter Group	November-2024	Market Sale (Disposal) 20th Nov 2024	8.75 %	₹ 50.65	9.00 lac	₹ 4.56 cr
Haresh Kapurlal Mehta Promoter & Director	January-2024	Inter-se Transfer (Disposal) 10th Jan 2024	28.45 %	₹ 0.00	63.83 lac	₹ 0.00
Harshit Haresh Mehta Promoter & Director	January-2024	Inter-se Transfer (Acquisition) 10th Jan 2024	9.11 %	₹ 0.00	19.60 lac	₹ 0.00

Corporate Actions

History of Medico Remedies Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Stock Split1 : 5
Ex-date: 16th Mar 2023Announced on: 2nd Feb 2023
Nominal value change from INR 10 to INR 2.
Bonus3 new shares for 1 existing shares
Ex-date: 16th Nov 2021Announced on: 7th Oct 2021

Company Profile

Overview of Medico Remedies Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretrovir...

Key personnel

Mr. Kunal Vora

Additional Non-Executive Independent Director

Ms. Vidhi Ankit Shah

Compliance Officer, Company Secretary

Mr. Gopal Jha

Administration Manager

Mrs. Priyal Mehta

Marketing Manager

Mr. Dushant Pandey

Quality Control Manager

Mr. Haresh MehtaD

Chairman of the Board, Legal Head and Chief Financial Officer

Mr. Harshit Haresh MehtaD

Managing Director, Marketing & Export Head and Executive Director

Mr. Rishit Hareshbhai (Rishi) MehtaD

Production - Technical & Quality Control Head and Whole-time Director

View all

Incorporated on

18 Mar 1994

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

08 Feb 2018

Free Float

2,53,51,846

Website

https://www.medicoremediesindia.com/

Phone no.

+918046047706

Address

1105/1106, 11TH FLOOR, HUBTOWN SOLARIS OPP, TELLI GALLI, N S PHADKE MARG, ANDHERI EAST, , 400069, India

Frequently Asked Questions

What is the current share price of Medico Remedies Ltd.?

The current share price of Medico Remedies Ltd. is ₹ 41.84 as of 25 Aug 2026.

What is the market capitalisation of Medico Remedies Ltd.?

The market capitalisation of Medico Remedies Ltd. stands at ₹ 349.28 Cr.

What is the PE ratio of Medico Remedies Ltd.?

The Price-to-Earnings (PE) ratio of Medico Remedies Ltd. is 25.28 as of the latest trailing twelve months data.

What is the ROE and ROCE of Medico Remedies Ltd.?

Medico Remedies Ltd. has a Return on Equity (ROE) of 19.02% and a Return on Capital Employed (ROCE) of 16.21% as per the latest financial reports.

What is the 52-week high and low of Medico Remedies Ltd.?

The 52-week high of Medico Remedies Ltd. is - and the 52-week low is -.

What is the dividend yield of Medico Remedies Ltd.?

The dividend yield of Medico Remedies Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Medico Remedies Ltd.?

Foreign Institutional Investors (FII) hold 0.08%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 33.82% of Medico Remedies Ltd. shares.

What sector does Medico Remedies Ltd. belong to?

Medico Remedies Ltd. operates in the Healthcare sector.

What is the beta of Medico Remedies Ltd.?

The beta of Medico Remedies Ltd. is 0.94, indicating its price volatility relative to the broader market. Over the past 1 year, Medico Remedies Ltd. has delivered an absolute return of 2.26%.

What is the RSI of Medico Remedies Ltd.?

The 14-day Relative Strength Index (RSI) of Medico Remedies Ltd. is 42.51, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Medico Remedies Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Medico Remedies Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile